Drug
Sar442970
Sar442970: highest development phase Phase 2, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| SAR442970 NCT06975722 | Phase 2 | Ulcerative Colitis |
Latest
No recent events.
Follow Sar442970 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.